MindMed to Present at the 2025 RBC Capital Markets Global Healthcare Conference

Audio By Carbonatix

NEW YORK--(BUSINESS WIRE)--May 13, 2025--

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that members of the Company’s management team will present at the 2025 RBC Capital Markets Global Healthcare Conference:

• 2025 RBC Capital Markets Global Healthcare Conference
  • Format: Fireside Chat and 1x1 Meetings
  • Date: May 21, 2025, at 2:05 PM ET
  • Location: New York, NY
  • Webcast Link: 2025 RBC Capital Markets Global Healthcare Conference

Audio webcasts and replays of available presentations will be accessible on MindMed’s Investor Relations website for up to 90 days following each event.

About MindMed

MindMed is a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders. Our mission is to be the global leader in the development and delivery of treatments that unlock new opportunities to improve patient outcomes. We are developing a pipeline of innovative product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways that play key roles in brain health. MindMed trades on Nasdaq under the symbol MNMD.

View source version on businesswire.com:https://www.businesswire.com/news/home/20250513189014/en/

CONTACT: For Media:[email protected]

For Investors:[email protected]

KEYWORD: UNITED STATES NORTH AMERICA CANADA NEW YORK

INDUSTRY KEYWORD: HEALTH NEUROLOGY GENERAL HEALTH RESEARCH SCIENCE PHARMACEUTICAL BIOTECHNOLOGY

SOURCE: Mind Medicine (MindMed) Inc.

Copyright Business Wire 2025.

PUB: 05/13/2025 07:00 AM/DISC: 05/13/2025 07:02 AM

http://www.businesswire.com/news/home/20250513189014/en